
InflaRx N.V.
IFRXHealthcare|Biotechnology|DE
$1.30
-0.05 (-3.69%)
DCF Value
$0.19
Tangible Book / Share
$0.98
Cash / Share
$0.78
Ownership Breakdown
85.2%
Float
147.4M
Shares Outstanding
125.6M
Float Shares
Major Holders (31)
Combined: 165.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Aaron Cowen | HC, IN | 15.60% | 22,933,910 | Aug 14, 2026 | 13D/G |
| Montanova Capital, LLC | IA, OO | 15.60% | 22,933,910 | Aug 14, 2026 | 13D/G |
| Averill Master Fund, Ltd. | Corporation | 12.50% | 18,460,710 | Aug 14, 2026 | 13D/G |
| Suvretta Capital Management, LLC | IA, OO | 11.70% | 7,933,910 | Feb 13, 2026 | 13D/G |
| Chen Yu | Individual | 9.80% | 14,500,000 | May 12, 2026 | 13D/G |
| TCG Crossover Fund III, L.P. | Partnership | 9.80% | 14,500,000 | May 12, 2026 | 13D/G |
| TCG Crossover GP III, LLC | Other | 9.80% | 14,500,000 | May 12, 2026 | 13D/G |
| Alex Silverstein | HC, IN | 6.10% | 8,911,348 | Aug 14, 2026 | 13D/G |
| Sirenia Capital Management LP | IA, PN | 6.10% | 8,911,348 | Aug 14, 2026 | 13D/G |
| FMR LLC | Holding company | 5.50% | 8,163,341 | Aug 6, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 5.50% | 8,163,341 | Aug 6, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 5.10% | 7,475,000 | Aug 17, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 5.10% | 7,475,000 | Aug 17, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 5.10% | 7,475,000 | Aug 17, 2026 | 13D/G |
| Commodore Capital LP | IA, PN | 5.10% | 7,475,000 | Aug 17, 2026 | 13D/G |
| Husen, Avner A. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Giauque, Nicolas | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Gehani, Varun N. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Dunn Hannah E. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Dreyfuss, Philip D. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Linn, Michael G. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Luo Patrick (Cheng) | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Roberts, Jr., Thomas G. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Saito Edric C. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Short Daniel S. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Spokes, Andrew J. M. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Warren, John R. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Wehrly, Mark C. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Farallon Capital Management, L.L.C. | IA, OO | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Kim, David T. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
| Dapice Joshua J. | HC, IN | 2.30% | 3,325,000 | Aug 14, 2026 | 13D/G |
Insider Trades (60)
Last 4 quarters: 0 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 30,000 | $1.86 | $55.8K | Form 4 |
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 30,000 | $2.37 | $71.1K | Form 4 |
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 30,000 | $1.79 | $53.7K | Form 4 |
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 30,000 | $2.41 | $72.3K | Form 4 |
| Brudnick Richard | director | Mar 18, 2026 | OTHER | 30,000 | $1.17 | $35.1K | Form 4 |
| Hellstrom Hege | director | Mar 18, 2026 | OTHER | 22,500 | $4.19 | $94.3K | Form 4 |
| Hellstrom Hege | director | Mar 18, 2026 | OTHER | 30,000 | $1.79 | $53.7K | Form 4 |
| Hellstrom Hege | director | Mar 18, 2026 | OTHER | 30,000 | $2.41 | $72.3K | Form 4 |
| Hellstrom Hege | director | Mar 18, 2026 | OTHER | 30,000 | $1.17 | $35.1K | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 430,500 | $1.86 | $800.7K | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 55,000 | $2.44 | $134.2K | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 430,500 | $2.37 | $1.0M | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 500,000 | $1.79 | $895.0K | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 500,000 | $2.41 | $1.2M | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 571,500 | $1.17 | $668.7K | Form 4 |
| Guo Renfeng | director, officer: Chief Scientific Officer | Mar 18, 2026 | OTHER | 171,450 | $1.17 | $200.6K | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 7,308 | $0.01 | $95.73 | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 30,000 | $1.86 | $55.8K | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 30,000 | $2.37 | $71.1K | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 30,000 | $1.79 | $53.7K | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 30,000 | $2.41 | $72.3K | Form 4 |
| Kubler Mark | director | Mar 18, 2026 | OTHER | 30,000 | $1.17 | $35.1K | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 30,000 | $1.86 | $55.8K | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 30,000 | $2.37 | $71.1K | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 30,000 | $1.79 | $53.7K | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 30,000 | $2.41 | $72.3K | Form 4 |
| Gibney Anthony S | director | Mar 18, 2026 | OTHER | 30,000 | $1.17 | $35.1K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 20,000 | $2.44 | $48.8K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 25,000 | $2.37 | $59.3K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 45,000 | $1.79 | $80.5K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 70,000 | $2.41 | $168.7K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 70,000 | $1.17 | $81.9K | Form 4 |
| OCarroll Derval | See Remarks | Mar 18, 2026 | OTHER | 21,000 | $1.17 | $24.6K | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 45,000 | $1.86 | $83.7K | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 45,000 | $2.37 | $106.7K | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 45,000 | $1.79 | $80.5K | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 45,000 | $2.41 | $108.5K | Form 4 |
| Fulpius Nicolas | director | Mar 18, 2026 | OTHER | 45,000 | $1.17 | $52.6K | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 126,005 | $0.02 | $1.9K | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 548,000 | $1.86 | $1.0M | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 55,000 | $2.44 | $134.2K | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 548,000 | $2.37 | $1.3M | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 635,000 | $1.79 | $1.1M | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 635,000 | $2.41 | $1.5M | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 635,000 | $1.17 | $743.0K | Form 4 |
| Riedemann Niels | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 190,500 | $1.17 | $222.9K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 110,000 | $1.86 | $204.6K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 55,000 | $2.44 | $134.2K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 110,000 | $2.37 | $260.7K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 210,000 | $1.79 | $375.9K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 240,000 | $2.41 | $578.4K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 240,000 | $1.17 | $280.8K | Form 4 |
| Taapken Thomas | Chief Financial Officer | Mar 18, 2026 | OTHER | 72,000 | $1.17 | $84.2K | Form 4 |